*  Tumor-infiltrating lymphocytes
Immunotherapy Doubts Fading in GI Cancers. April 2016 Syn, Nicholas L; Teng, Michele W L; Mok, Tony S K; Soo, Ross A. "De-novo ... An active immune environment within the tumor often indicates a better prognosis as can be determined by the Immunological ... The presence of lymphocytes in tumors is often associated with better clinical outcomes (after surgery or immunotherapy). When ... Correlation with the postsurgical clinical course". Cancer Immunology, Immunotherapy. 21 (1): 69-76. doi:10.1007/BF00199380. ...
*  Allergen immunotherapy
... "have had the good fortune to develop an active immunity against the toxin." He hypothesized that by injecting hay fever ... Sublingual immunotherapy is also found to have a better safety profile than subcutaneous immunotherapy since the local side ... The guidelines acknowledge that sublingual immunotherapy is safer than subcutaneous immunotherapy. World Allergy Organisation ... production and quality of immunotherapy products with a view to register allergen immunotherapy as pharmaceutical specialties. ...
*  Monoclonal antibody therapy
Monoclonal antibodies can be acquired in the immune system via passive immunity or active immunity.The advantage of active ... Immunotherapy developed in the 1970s following the discovery of the structure of antibodies and the development of hybridoma ... In mice expressing APP, both active and passive immunization of anti-Aβ antibodies has been shown to be effective in clearing ... Immunotherapy via exogenous monoclonal antibody (MAB) administration has been known to treat various central nervous disorders ...
*  Active immunotherapy
... , Mantle cell lymphoma#Immunotherapy, "Heat-shock protein vaccines as active immunotherapy against human ... Active immunotherapy is a type of immunotherapy that attempts to stimulate the host's intrinsic immune response to a disease e. ... Specific Active Immunotherapy: The generation of cell-mediated and antibody immune responses focused on specific antigens ... It divides into: Non-Specific Active Immunotherapy: Generating a general immune system response using cytokines and other cell ...
*  List of cocaine analogues
Kinsey, BM; Kosten, TR; Orson, FM (2010). "Active immunotherapy for the Treatment of Cocaine Dependence". Drugs Future. 35: 301 ... This is remarkable considering unmodified (native) benztropine is 60 times more active as an anticholinergic than as a ...
*  Immunity (medical)
The birth of active immunotherapy may have begun with Mithridates VI of Pontus. To induce active immunity for snake venom, he ... Active immunity often involves both the cell-mediated and humoral aspects of immunity as well as input from the innate immune ... Naturally acquired active immunity occurs when a person is exposed to a live pathogen, and develops a primary immune response, ... Artificially acquired active immunity can be induced by a vaccine, a substance that contains antigen. A vaccine stimulates a ...
*  Cancer immunotherapy
Immunotherapies can be categorized as active, passive or hybrid (active and passive). These approaches exploit the fact that ... Active immunotherapy directs the immune system to attack tumor cells by targeting TAAs. Passive immunotherapies enhance ... What is Cancer Immunotherapy Association for Immunotherapy of Cancer Society for Immunotherapy of Cancer "And Then There Were ... Active cytotoxic T-cells are required for the immune system to attack melanoma cells. Normally inhibited active melanoma- ...
*  Mantle cell lymphoma
In contrast to these antibody-based 'passive' immunotherapies, the field of 'active' immunotherapy tries to activate a ... Though no active immunotherapies are currently a standard of care, numerous clinical trials are ongoing. In November 2013, ... Examples of active immunotherapy include cancer vaccines, adoptive cell transfer, and immunotransplant, which combines ... mantle cell lymphoma is potentially curable with very intensive chemo-immunotherapy followed by a stem cell transplant, when ...
*  Vaccinogen
January 30, 1999). "Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial". Lancet. ... Mar 21, 2001). "Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell ... Hanna MG Jr; Hoover HC Jr; Pinedo HM; Finer M. (July 6, 2006). "Active specific immunotherapy with autologous tumor cell ... Mar 1, 1993). "Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III ...
*  Biovest
Their active immunotherapy, BiovaxID, is a cancer vaccine whose first indication is intended to be consolidation/adjuvant ...
*  Immunotherapy
Immunomodulators are the active agents of immunotherapy. They are a diverse array of recombinant, synthetic, and natural ... while immunotherapies that reduce or suppress are classified as suppression immunotherapies. In recent years, immunotherapy has ... Immunotherapy may produce long-term benefits. Immunotherapy is partly effective in some people and ineffective in others, but ... Immunotherapy is the "treatment of disease by inducing, enhancing, or suppressing an immune response". Immunotherapies designed ...
*  Ariel Hollinshead
Hollinshead, A (1991). "Active specific immunotherapy and immunochemotherapy in the treatment of lung and colon cancer". ... because of her 280 published articles on active immunotherapy, and developing, managing, and testing the epitome activity for ... "Adjuvant specific active lung cancer immunotherapy trials. Tumor-associated antigens" (PDF). Cancer. 60 (6): 1249-62. PMID ... In 2013 she was recognized by GWAA (George Washington Alumni Association) for being the "Mother of Immunotherapy". 2014 She was ...
*  Neurodegeneration
The goal of immunotherapy is to enhance aspects of the immune system. Both active and passive vaccinations have been proposed ... Brody DL, Holtzman DM (2008). "Active and Passive Immunotherapy for Neurodegenerative Disorders". Annual Review of Neuroscience ...
*  Transgene SA
TG4010, a specific active immunotherapy to treat MUC1-expressing solid tumors, is currently being tested in non-small-cell lung ... an immunotherapy product that is in Phase II clinical trials for the treatment of chronic hepatitis C infections (HCV); and ... "JX-594 demonstrated oncolytic and immunotherapy MOA, tumor responses and dose-related survival in individuals with HCC." In ... 2970107-4/fulltext JX-594 demonstrated oncolytic and immunotherapy MOA, tumor responses and dose-related survival in ...
*  Bavarian Nordic
Prostvac is an active immunotherapy candidate, currently the subject of a global Phase 3 clinical study "PROSPECT" in men with ... development and manufacture of active cancer immunotherapies and vaccines for infectious diseases. The company is headquartered ... A second poxvirus-based technology is employed in most of the company's cancer immunotherapies, and was in-licensed as part of ... The poxvirus-based immunotherapy can be modified to encode different tumor-associated antigens such as Prostate-specific ...
*  Cadila Pharmaceuticals
... first in the class active immunotherapy as well as drug targeting Desmocollin. Some of the top brands of the company are Aciloc ... Cadila Pharmaceuticals manufactures and sells finished formulations and active pharmaceutical ingredients (APIs) in 100 ...
*  C-Met
Active immunotherapy to MET-expressing tumors can be achieved by administering cytokines, such as interferons (IFNs) and ... Drugs used for immunotherapy can act either passively by enhancing the immunologic response to MET-expressing tumor cells, or ... Abnormal MET activation in cancer correlates with poor prognosis, where aberrantly active MET triggers tumor growth, formation ... Administering monoclonal antibodies (mAbs) is a form of passive immunotherapy. MAbs facilitate destruction of tumor cells by ...
*  PPF (company)
SOTIO is a biotechnology company developing a new Active Cellular Immunotherapy ("ACI") for the treatment of cancer and ... It's active in the Czech Republic, Slovakia, Netherlands, Russia, Kazakhstan, Germany, Belarus, India, Indonesia, Vietnam, ...
*  List of MeSH codes (E02)
... immunotherapy, active MeSH E02.095.520.400.530.890 --- vaccination MeSH E02.095.520.400.650 --- mass immunization MeSH E02.095. ... active MeSH E02.760.905.199.249.200 --- euthanasia, active, voluntary MeSH E02.760.905.199.249.750 --- euthanasia, animal MeSH ... highly active MeSH E02.319.452.150 --- estrogen replacement therapy MeSH E02.319.703.150 --- antibiotic prophylaxis MeSH ... immunotherapy, adoptive MeSH E02.095.520.400.470 --- immunization schedule MeSH E02.095.520.400.485 --- immunization, secondary ...
*  Jonathan Lewis (oncologist)
This includes the early use of peptides and DNA vaccines with active immunotherapy using T cells, a better understanding of the ...
*  Index of immunology articles
... deaminase Active hexose correlated compound Active immunotherapy Acute-phase protein Adaptive immune system Adipose tissue ... STAT4 STAT5 STAT6 Stem cell educator Stimulator of interferon genes Stromal cell-derived factor 1 Sublingual immunotherapy ... receptor type 6 C-C chemokine receptor type 7 Calreticulin Cancer immunology Cancer immunoprevention Cancer immunotherapy ... macrophages Adoptive immunity Affinity maturation Allele frequency net database Allergen Allergen immunotherapy Allergy ...
*  Outline of immunology
Artificial induction of immunity Immunization Active immunotherapy Passive immunity Temporarily induced immunity Adoptive ... Prevention Immunostimulants Immunotherapy Activation immunotherapy Cancer immunotherapy Autologous immune enhancement therapy ... Immunosuppression Sublingual immunotherapy Allergen immunotherapy Immunosuppressive drug ...
*  Dendritic cells- based cancer vaccines
It is an active cellular immunotherapy, which involves obtaining antigen-presenting autologous dendritic cells from the patient ... DC-based immunotherapy approach can be employed in a couple of ways: Most of trials testing in vivo DCs' stimulation with ... DC-based immunotherapy is safe and can promote antitumor immune responses and prolonged survival of cancer patients. Non- ... Hammerstrom, Aimee E.; Cauley, Diana H.; Atkinson, Bradley J.; Sharma, Padmanee (2011-8). "Cancer Immunotherapy: Sipuleucel-T ...
*  Keyhole limpet hemocyanin
The rapidly growing interest in therapeutic vaccines (i.e. active immunotherapies) for cancer and the documented efficacy of ... November 2012). "Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by ...
*  Radiation therapy
Combining radiation therapy with immunotherapy is an active area of investigation and has shown some promise for melanoma and ... immunotherapy or some mixture of the four. Most common cancer types can be treated with radiation therapy in some way. The ...
*  Interferon
Viral interference refers to the inhibition of virus growth caused by previous exposure of cells to an active or a heat- ... L03AB Interferons Immunosuppression Immunosuppressive drug Immunotherapy Interferon Consensus Sequence-binding protein De ... Chris Y.H. Tan and his co-workers purified and produced biologically active, radio-labeled human beta interferon by ... superinducing the interferon gene in fibroblast cells, and they showed its active site contains tyrosine residues. Tan's ...
*  Egg allergy
There is active research on trying oral immunotherapy (OIT) to desensitize people to egg allergens. A Cochrane Review concluded ... "Oral and sublingual immunotherapy for egg allergy". Cochrane Database Syst Rev (11): CD010638. doi:10.1002/14651858.CD010638. ... "Comprehensive Review of Current Knowledge on Egg Oral Immunotherapy". J Investig Allergol Clin Immunol. 25 (5): 316-28; quiz 2 ...